Alzheimer DiseaseMedication AdherenceMemory DisordersAmyloid beta-PeptidesQuestionnairestau ProteinsAmyloid beta-Protein PrecursorNeurofibrillary TanglesPlaque, AmyloidBrainApolipoprotein E4Amyloid Precursor Protein SecretasesCognition DisordersDementiaPresenilin-1AmyloidAtrophyDementia, VascularNeuropsychological TestsNeurofibrilsMild Cognitive ImpairmentApolipoproteins EPresenilin-2Peptide FragmentsMental Status ScheduleHippocampusCognitionMagnetic Resonance ImagingLewy Body DiseaseMemantineAge of OnsetPresenilinsAgingAspartic Acid EndopeptidasesAniline CompoundsNeuronsCholinesterase InhibitorsMice, TransgenicNational Institute on Aging (U.S.)Substantia InnominataCerebral CortexCerebral Amyloid AngiopathyLongitudinal StudiesAmyloidogenic ProteinsAutopsyBrain ChemistryPositron-Emission TomographyDisease ProgressionNerve DegenerationProtease NexinsProdromal SymptomsPhenylcarbamatesDisease Models, AnimalTauopathiesNeurodegenerative DiseasesIndansNootropic AgentsDown SyndromeGenetic Predisposition to DiseaseLewy BodiesClioquinolThiazolesFrontotemporal DementiaBiological MarkersAmnesiaGenotypeTemporal LobePsychomotor AgitationNerve Tissue ProteinsNeuropil ThreadsCase-Control StudiesCohort StudiesInsulysinApolipoprotein E3TacrineMemoryChromosomes, Human, Pair 21Monomeric Clathrin Assembly ProteinsPhosphorylationReference ValuesParkinson DiseaseMutationApolipoprotein E2Kluver-Bucy SyndromeGalantamineRisk FactorsFrontotemporal Lobar DegenerationBenzothiazolesGenetic TestingNeurocalcinAmyloidosisLDL-Receptor Related ProteinsCA2 Region, HippocampalNerve Fibers, MyelinatedAllelesGlycogen Synthase Kinase 3CaregiversSeverity of Illness IndexCyclin-Dependent Kinase 5Postmortem Changes